Copyright
©2012 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. Dec 6, 2012; 3(6): 86-92
Published online Dec 6, 2012. doi: 10.4292/wjgpt.v3.i6.86
Published online Dec 6, 2012. doi: 10.4292/wjgpt.v3.i6.86
Figure 1 Mean of serum glutamate oxaloacetate transaminase, serum glutamate pyruvate transaminase and alkaline phosphatase levels measured terminally (n = 6).
Normal control, carbon tetrachloride (CCl4) control, silymarin (100 mg/kg), heparin (2000 IU/kg), silymarin and heparin (combination) group and control treated animals. SGOT: Serum glutamate oxaloacetate transaminase; SGPT: Serum glutamate pyruvate transaminase; ALP: Alkaline phosphatase. aP < 0.05; bP < 0.01; dP < 0.001. A: Normal control vs CCl4 control; B: CCl4 control vs treatment group; C: Normal control vs control treated.
- Citation: Shah B, Shah G. Antifibrotic effect of heparin on liver fibrosis model in rats. World J Gastrointest Pharmacol Ther 2012; 3(6): 86-92
- URL: https://www.wjgnet.com/2150-5349/full/v3/i6/86.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v3.i6.86